980-nm Diode laser: a novel laser technology for vaporization of the prostate.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMID 17611013)

Published in Eur Urol on June 26, 2007

Authors

Gunnar Wendt-Nordahl1, Stephanie Huckele, Patrick Honeck, Peter Alken, Thomas Knoll, Maurice Stephan Michel, Axel Häcker

Author Affiliations

1: Department of Urology, University Hospital Mannheim, Mannheim, Germany. gunnar.wendt-nordahl@uro.ma.uni-heidelberg.de

Articles citing this

Management of ear lobule keloids using 980-nm diode laser. Eur Arch Otorhinolaryngol (2011) 1.63

Complications of laser prostatectomy: a review of recent data. World J Urol (2010) 1.22

High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci (2008) 0.98

New alternatives for laser vaporization of the prostate: experimental evaluation of a 980-, 1,318- and 1,470-nm diode laser device. World J Urol (2009) 0.87

The Twister laser fiber degradation and tissue ablation capability during 980-nm high-power diode laser ablation of the prostate. A randomized study versus the standard side-firing fiber. Lasers Med Sci (2011) 0.86

Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci (2008) 0.80

Twelve-Month Follow-up Results of Photoselective Vaporization of the Prostate With a 980-nm Diode Laser for Treatment of Benign Hyperplasia. Korean J Urol (2013) 0.80

Initial Experiences with a 980 nm Diode Laser for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia. Korean J Urol (2011) 0.80

Update on the use of diode laser in the management of benign prostate obstruction in 2014. World J Urol (2014) 0.79

Ex vivo efficacy evaluation of laser vaporization for treatment of benign prostatic hyperplasia using a 300-W high-power laser diode with a wavelength of 980 nm. Laser Ther (2014) 0.78

A comparative study of diode laser and plasmakinetic in transurethral enucleation of the prostate for treating large volume benign prostatic hyperplasia: a randomized clinical trial with 12-month follow-up. Lasers Med Sci (2016) 0.78

Diode laser (980 nm) enucleation of the prostate: a promising alternative to transurethral resection of the prostate. Lasers Med Sci (2012) 0.77

Tissue damage by laser radiation: an in vitro comparison between Tm:YAG and Ho:YAG laser on a porcine kidney model. Springerplus (2016) 0.75

A Systematic Review and Meta-Analysis of Functional Outcomes and Complications Following the Photoselective Vaporization of the Prostate and Monopolar Transurethral Resection of the Prostate. World J Mens Health (2016) 0.75

Re: Gunnar Wendt-Nordahl, Stephanie Huckele, Patrick Honeck, et al. 980-nm diode laser: A novel laser technology for vaporization of the prostate. Eur Urol 2007;52:1723-8. Eur Urol (2008) 0.75

Diode laser vaporisation of the prostate vs. diode laser under cold irrigation: A randomised control trial. Arab J Urol (2014) 0.75

Novel treatment strategy for refractory hemorrhagic cystitis following radiation treatment of genitourinary cancer: Use of 980-nm diode laser. Lasers Med Sci (2012) 0.75

Analysis of Thermally Denatured Depth in Laser Vaporization for Benign Prostatic Hyperplasia using a Simulation of Light Propagation and Heat Transfer (secondary publication). Laser Ther (2016) 0.75

Articles by these authors

2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44

2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98

Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol (2007) 2.09

Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91

Shock wave technology and application: an update. Eur Urol (2011) 1.77

Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol (2011) 1.55

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol (2009) 1.52

Flexible ureterorenoscopy for the treatment of lower pole calyx stones: influence of different lithotripsy probes and stone extraction tools on scope deflection and irrigation flow. Eur Urol (2002) 1.50

5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 1.50

Physiologic bladder evacuation with selective sacral root stimulation: sinusoidal signal and organ-specific frequency. Neurourol Urodyn (2002) 1.41

Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40

Radical cystectomy--often too late? 1987. Eur Urol (2006) 1.38

Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience. World J Urol (2013) 1.37

Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer. Int J Cancer (2003) 1.34

High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol (2002) 1.33

120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol (2010) 1.29

Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer (2008) 1.27

Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res (2005) 1.22

Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol (2002) 1.21

Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol (2009) 1.18

Three-dimensional laparoscopic imaging improves surgical performance on standardized ex-vivo laparoscopic tasks. J Endourol (2012) 1.17

Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15

Diverticular carcinoma of the urinary bladder: diagnosis and treatment problems. A case report. Med Princ Pract (2005) 1.13

Standardization strategy for quantitative PCR in human seminoma and normal testis. J Biotechnol (2005) 1.13

Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study. J Endourol (2010) 1.09

Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol (2003) 1.08

Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek? BJU Int (2005) 1.08

Validation of computer-based training in ureterorenoscopy. BJU Int (2005) 1.08

70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int (2009) 1.05

Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest (2002) 1.05

The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol (2004) 1.04

Flexible ureterorenoscopy for lower pole stones: influence of the collecting system's anatomy. J Endourol (2013) 1.04

Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones. BJU Int (2007) 1.03

A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol (2007) 1.02

Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol (2004) 1.02

Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomy. J Endourol (2009) 1.02

Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int (2008) 0.99

Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol (2011) 0.99

Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int (2005) 0.99

Live surgical education: a perspective from the surgeons who perform it. BJU Int (2014) 0.97

The past, present and future of minimally invasive therapy in urology: a review and speculative outlook. Minim Invasive Ther Allied Technol (2013) 0.97

Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res (2005) 0.96

Risk of collateral damage to endourologic tools by holmium:YAG laser energy. J Endourol (2006) 0.93

Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol (2007) 0.92

Do new generation flexible ureterorenoscopes offer a higher treatment success than their predecessors? Urol Res (2010) 0.91

Flexible ureterorenoscopy versus miniaturized PNL for solitary renal calculi of 10-30 mm size. World J Urol (2011) 0.90

Radiation exposure during endourologic procedures using over-the-table fluoroscopy sources. J Endourol (2011) 0.90

Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol (2012) 0.89

Effect of pulse energy, frequency and length on holmium:yttrium-aluminum-garnet laser fragmentation efficiency in non-floating artificial urinary calculi. J Endourol (2010) 0.89